Developing a knowledge transfer and exchange strategy for a clinical trials unit

为临床试验部门制定知识转移和交流策略

阅读:1

Abstract

NEED FOR A STRATEGIC APPROACH TO KNOWLEDGE TRANSFER AND EXCHANGE: Late-phase clinical trials and systematic reviews find results that have the potential to improve health outcomes for people. However, there are often delays in these results influencing clinical practice. We developed a knowledge transfer and exchange strategy to support research teams, aiming to identify activities along the research process to maximise and accelerate the research impact. OUR KNOWLEDGE TRANSFER AND EXCHANGE STRATEGY: The strategy has five strands of activity across the life-course of our research: 1. Partnerships with external stakeholders (including patient and public involvement, charities, policymakers, healthcare professionals, professional bodies, regulators and industry) 2. Communication (including the development of research impact strategies and use of communication tools and channels) 3. Maximising the scientific value of our studies (including open access, data and sample sharing, and incorporating multi-disciplinary components within studies) 4. Strengthening capacity (including building internal and partner capacity to communicate effectively, and strengthening the capacity of external stakeholders to understand and apply our research). 5. Learning and sharing (evaluating the impact of research, sharing lessons learnt internally and externally) The strategy has helped trial teams think systematically about impact and was easy to use. CONCLUSIONS: Our strategy helps researchers systematically identify activities which may improve the usefulness and uptake of their study results. While developed in a single trials unit, we think it may be of use to others.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。